Charles River Laboratories International, Inc. · NYSE:CRL
Mackay Martin received 2,845 Charles River Laboratories International, Inc. shares as an award (Form 4)
Traded May 8, 2026 · Filed May 11, 2026
On May 8, 2026, Mackay Martin (Director) received 2,845 Charles River Laboratories International, Inc. shares as an award at US$177.62 for US$505K, leaving 17,137 shares. Filed May 11, 2026 (Form 4).
- Awarded
- 2,845 shares
- Price
- US$177.62
- Value
- US$505K
- Holding after
- 17,137 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 8, 2026 | Common Stock | Award | 1,438 | US$177.62 | 15,730 | Direct |
| May 8, 2026 | Common Stock | Award | 1,407 | US$177.62 | 17,137 | Direct |
Source
Related
- Charles River Laboratories International, Inc.
- Mackay Martin
- Charles River Laboratories International, Inc. shareholders
- Form 4 · Parisotto Shannon M · Oct 7, 2026
- Form 4 · Coleman Glenn · Oct 2, 2026
- Schedule 13G/A · FMR LLC · Sep 8, 2026
- Form 4 · Foster James C · Aug 27, 2026
- Form 4 · Girshick Birgit · Aug 20, 2026